These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12425272)

  • 1. Schizophrenia. New drugs, renewed hope.
    Mayo Clin Health Lett; 2002 Oct; 20(10):7. PubMed ID: 12425272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Older antipsychotic drugs have proven to be equally effective with the newer treatments].
    Salokangas RK
    Duodecim; 2005; 121(24):2617-9. PubMed ID: 16454243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of novel antipsychotic drugs on quality of life among people suffering from schizophrenia.
    Jukić V; Barić V; Culav-Sumić J; Herceg M; Majdancić Z; Werft-Cop M
    Coll Antropol; 2003; 27 Suppl 1():119-24. PubMed ID: 12955901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation antipsychotic drugs and compliance behaviour.
    Voruganti LP; Baker LK; Awad AG
    Curr Opin Psychiatry; 2008 Mar; 21(2):133-9. PubMed ID: 18332660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Promising effects of the new antipsychotic agents in schizophrenia. But recommendations of the Medical Products Agency are conservative].
    Sedvall GC
    Lakartidningen; 1997 May; 94(20):1873-6. PubMed ID: 9190476
    [No Abstract]   [Full Text] [Related]  

  • 7. Do findings from new trials for schizophrenia fit with existing evidence: not duped...just beguiled?
    Adams CE; Jayaram M
    Epidemiol Psichiatr Soc; 2007; 16(3):199-202. PubMed ID: 18020192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Social cognition and atypical antipsychotic agents in the treatment of persons with schizophrenia: preliminary data from a naturalistic study].
    Mazza M; Tozzini C; Giosué P; De Risio A; Palmucci M; Roncone R; Casacchia M
    Clin Ter; 2003; 154(2):79-83. PubMed ID: 12856365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on "Optimizing early prediction for antipsychotic response in schizophrenia" by Chang et al.
    Chen L; Kollack-Walker S; Lipkovich IA
    J Clin Psychopharmacol; 2009 Jun; 29(3):311-2. PubMed ID: 19440095
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.
    Miyamoto S; Duncan GE; Marx CE; Lieberman JA
    Mol Psychiatry; 2005 Jan; 10(1):79-104. PubMed ID: 15289815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern-Antipsychotics study.
    Yoshimura R; Okamoto T; Nakamura J; Tateno M; Otsuka K; Takahashi H; Fujisawa D; Takamatsu T; Fujii S; Sato S; Inoue M; Sasaki H; Kuroki T; Shinfuku N
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):778-9. PubMed ID: 17109719
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia.
    Citrome L
    Int J Clin Pract; 2008 May; 62(5):837-40. PubMed ID: 18412940
    [No Abstract]   [Full Text] [Related]  

  • 18. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
    Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
    Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia].
    Kleszczewska E; Hejza J
    Pol Merkur Lekarski; 2003 Feb; 14(80):136-8. PubMed ID: 12728674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.